Oxford Immunotec Global PLC appointed Mark Klausner to the board.
Klausner is the co-founder and managing partner of Westwicke Partners, a capital markets advisory and investor relations firm focused on the healthcare industry.
Oxford Immunotec is a U.K.-based diagnostics company.
